SCN3A — NaV1.3

SCN3A (NaV1.3) is a lever-L1 non-opioid analgesic target. Its promoter reads γ = 1.2645, placing it on the firing-threshold scale at |hsp| = 0.547301; the intervention direction is to reduce inward Na⁺. The read is reproducible [V]; the clinical magnitude is open [O].

SCN3A is read from its human promoter by the same deterministic engine used across the map (nearest-neighbour stacking energy → γ = 1.2645; R19 scale → |hsp| = 0.547301). The read places the gene in lever L1; its selectivity is cited Layer-2 biology, and every clinical magnitude (potency, dose, efficacy, safety) is graded [O].

The read

SCN3A — NaV1.3 sits in the threshold map at γ = 1.2645, |hsp| = 0.547301 (barrier 0.39974). It belongs to lever L1; the intervention direction is to reduce inward Na⁺ (Na_V1.3, re-expressed/up-regulated after nerve injury).

selectivity (cited) developmentally regulated; up-regulated in injured DRG/CNS

burden Tier-1 neuropathic

Grades

Firewall. γ here is a read of promoter switch-threshold structure only — never this channel's activation voltage, a candidate's potency, a dosing quantity, an in-vivo selectivity, or a clinical effect. Those magnitudes are [O] open.

Source

Hains 2003 J Neurosci 23:8881 (Na_V1.3 up-regulation after injury) · reproduce the read (engine)

See also: its lever · prioritisation · grading.